Home LiteratureArticle Details
PMID: 4993339 Published · ppublish English Journal Article

Iron requirements and aluminum sensitivity of an hydroxamic acid-requiring strain of Bacillus megaterium.

Journal of bacteriology ·Vol. 105 ·No. 2 ·1971-02-00 ·Pages 589-94

Davis WB, McCauley MJ, Byers BR

Abstract

Bacillus megaterium strain ATCC 19213 secretes a ferric-chelating secondary hydroxamic acid, whereas a mutant (strain SK11) derived from it cannot produce a hydroxamate. Strain SK11 could be cultivated in a sucrose-mineral salts medium (treated with Chelex 100 to reduce trace metals) in the absence of added hydroxamate, if the inoculum was high. The lowest iron supplements necessary for maximal growth of both strains were equivalent (0.01 to 0.04 mug of iron per ml). Addition of either aluminum (0.5 mug/ml) or chromium (0.1 mug/ml) to the medium prevented full growth of strain SK11 at the minimal iron concentration, although elevated iron (1 mug/ml) reversed this inhibition. The iron-free secondary hydroxamate, Desferal, also abolished aluminum and chromium inhibition of strain SK11, producing maximal population densities at the low iron concentration. Growth of the hydroxamate-producing strain 19213 was not altered significantly by the aluminum or chromium levels which inhibited strain SK11. However, strain 19213 responded to these metals by increasing its secretion of a secondary hydroxamate. It was concluded that aluminum and chromium interfered with iron incorporation, either directly or by formation of nonutilizable aggregates with iron. The secondary hydroxamates may have overcome this interference by solubilization of iron for delivery to a single uptake process, or the ferric-hydroxamate chelate may enter the cell by an alternate route.

MeSH Terms
Aluminum/pharmacology Arthrobacter/metabolism Bacillus megaterium/drug effects,growth & development,metabolism Biological Assay Chromium/pharmacology Culture Media Densitometry
Chemicals
Culture Media Chromium Aluminum
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Davis W B
McCauley M J
Byers B R
References (9)
9 references, click to expand
  1. Iron-chelating hydroxamic acid (schizokinen) active in initiation of cell division in Bacillus megaterium.
    J Bacteriol. 1967 Jan;93(1):286-94 PMID: 4960152
  2. A schizokinen (siderochrome) auxotroph of Bacillus megaterium induced with N-methyl-N'-nitro-N-nitrosoguanidine.
    Biochem Biophys Res Commun. 1966 Aug 12;24(3):370-5 PMID: 4961150
  3. 2,3-Dihydroxybenzoate as a bacterial growth factor and its route of biosynthesis.
    Biochim Biophys Acta. 1967 Jul 25;141(2):319-31 PMID: 4292725
  4. Hydroxamic acids in nature.
    Science. 1967 Jun 16;156(3781):1443-7 PMID: 4304945
  5. Iron transport in Escherichia coli: relationship between chromium sensitivity and high iron requirement in mutants of Escherichia coli.
    J Bacteriol. 1969 Jun;98(3):1135-41 PMID: 4892367
  6. Iron transport in Escherichia coli: roles of energy-dependent uptake and 2,3-dihydroxybenzoylserine.
    J Bacteriol. 1969 Jun;98(3):1142-50 PMID: 4892368
  7. The influence exerted by Sideromycins on Poly-U-directed incorporation of phenylalanine in the S-30 fraction of Staphylococcus aureus.
    Arch Mikrobiol. 1969 Oct;68(2):99-106 PMID: 5365776
  8. Repression of phenolic acid-synthesizing enzymes and its relation to iron uptake in Bacillus subtilis.
    J Bacteriol. 1970 Jan;101(1):181-7 PMID: 4983647
  9. Mycobactins: iron-chelating growth factors from mycobacteria.
    Bacteriol Rev. 1970 Jun;34(2):99-125 PMID: 4918634
Article Info
Journal
Journal of bacteriology
Abbr.
J Bacteriol
ISSN
0021-9193
Published
1971-02-00
Pages
589-94
Language
English
Region
United States
NLM ID
2985120R
PMCID
PMC248429
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]